225 related articles for article (PubMed ID: 23046237)
21. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
22. New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Stockfleth E; Sibbring GC; Alarcon I
Acta Derm Venereol; 2016 Jan; 96(1):17-22. PubMed ID: 26068001
[TBL] [Abstract][Full Text] [Related]
23. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.
Sachs DL; Kang S; Hammerberg C; Helfrich Y; Karimipour D; Orringer J; Johnson T; Hamilton TA; Fisher G; Voorhees JJ
Arch Dermatol; 2009 Jun; 145(6):659-66. PubMed ID: 19528421
[TBL] [Abstract][Full Text] [Related]
24. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
25. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A; Kempers S; Lain E; Schlesinger T; Tyring S; Forman S; Ablon G; Martin G; Wang H; Cutler DL; Fang J; Kwan MR;
N Engl J Med; 2021 Feb; 384(6):512-520. PubMed ID: 33567191
[TBL] [Abstract][Full Text] [Related]
26. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization.
Ouchene L; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2019; 23(4):455-456. PubMed ID: 31337239
[No Abstract] [Full Text] [Related]
27. Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?
Jorizzo J
J Drugs Dermatol; 2004; 3(1):21-6. PubMed ID: 14964743
[TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil-induced exacerbation of rosacea.
Haddock ES; Cohen PR
Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329576
[TBL] [Abstract][Full Text] [Related]
29. Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
Malvehy J; Alarcon I; Montoya J; Rodríguez-Azeredo R; Puig S
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):258-65. PubMed ID: 26538346
[TBL] [Abstract][Full Text] [Related]
30. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.
Neugebauer R; Levandoski KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2018 Apr; 78(4):710-716. PubMed ID: 29277731
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial.
Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE
J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340
[TBL] [Abstract][Full Text] [Related]
32. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
33. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
34. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
36. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
[No Abstract] [Full Text] [Related]
37. Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion.
Stockfleth E; Heppt MV; Bégeault N; Delarue A
Acta Derm Venereol; 2023 Nov; 103():adv11954. PubMed ID: 37982726
[TBL] [Abstract][Full Text] [Related]
38. Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.
Augustin M; Tu JH; Knudsen KM; Erntoft S; Larsson T; Hanke CW
J Am Acad Dermatol; 2015 May; 72(5):816-21. PubMed ID: 25770879
[TBL] [Abstract][Full Text] [Related]
39. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream.
Shaffelburg M
J Drugs Dermatol; 2009 Jan; 8(1):35-9. PubMed ID: 19180894
[TBL] [Abstract][Full Text] [Related]
40. Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness.
Emmerich VK; Cull D; Kelly KA; Feldman SR
J Dermatolog Treat; 2022 Jun; 33(4):2075-2078. PubMed ID: 33947303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
